JP2015526446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015526446A5 JP2015526446A5 JP2015527590A JP2015527590A JP2015526446A5 JP 2015526446 A5 JP2015526446 A5 JP 2015526446A5 JP 2015527590 A JP2015527590 A JP 2015527590A JP 2015527590 A JP2015527590 A JP 2015527590A JP 2015526446 A5 JP2015526446 A5 JP 2015526446A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- peptide
- bind
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 210000000130 stem cell Anatomy 0.000 claims 14
- 206010028980 Neoplasm Diseases 0.000 claims 13
- 201000011510 cancer Diseases 0.000 claims 13
- 210000004027 cell Anatomy 0.000 claims 11
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims 4
- 102100034256 Mucin-1 Human genes 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 230000005907 cancer growth Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000009702 cancer cell proliferation Effects 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261683155P | 2012-08-14 | 2012-08-14 | |
| US61/683,155 | 2012-08-14 | ||
| US201261684654P | 2012-08-17 | 2012-08-17 | |
| US61/684,654 | 2012-08-17 | ||
| US201261693712P | 2012-08-27 | 2012-08-27 | |
| US61/693,712 | 2012-08-27 | ||
| PCT/US2012/060684 WO2013059373A2 (en) | 2011-10-17 | 2012-10-17 | Media for stem cell proliferation and induction |
| USPCT/US2012/060684 | 2012-10-17 | ||
| PCT/US2013/025981 WO2013123084A1 (en) | 2012-02-13 | 2013-02-13 | Method for detecting circulating fetal cells |
| USPCT/US2013/025981 | 2013-02-13 | ||
| US201361837560P | 2013-06-20 | 2013-06-20 | |
| US61/837,560 | 2013-06-20 | ||
| PCT/US2013/055015 WO2014028668A2 (en) | 2012-08-14 | 2013-08-14 | Stem cell enhancing therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017238427A Division JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015526446A JP2015526446A (ja) | 2015-09-10 |
| JP2015526446A5 true JP2015526446A5 (cg-RX-API-DMAC10.html) | 2016-10-06 |
| JP6664219B2 JP6664219B2 (ja) | 2020-03-13 |
Family
ID=50101604
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015527590A Active JP6664219B2 (ja) | 2012-08-14 | 2013-08-14 | 幹細胞増強治療法 |
| JP2017238427A Active JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
| JP2020037396A Pending JP2020109101A (ja) | 2012-08-14 | 2020-03-05 | 幹細胞増強治療法 |
| JP2021181985A Pending JP2022025136A (ja) | 2012-08-14 | 2021-11-08 | 幹細胞増強治療法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017238427A Active JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
| JP2020037396A Pending JP2020109101A (ja) | 2012-08-14 | 2020-03-05 | 幹細胞増強治療法 |
| JP2021181985A Pending JP2022025136A (ja) | 2012-08-14 | 2021-11-08 | 幹細胞増強治療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9932407B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2885000A4 (cg-RX-API-DMAC10.html) |
| JP (4) | JP6664219B2 (cg-RX-API-DMAC10.html) |
| CN (3) | CN108175856B (cg-RX-API-DMAC10.html) |
| AU (2) | AU2013302620B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2882222A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL237228B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014028668A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012504961A (ja) * | 2008-10-06 | 2012-03-01 | ミネルバ バイオテクノロジーズ コーポレーション | Ｍｕｃ１＊抗体 |
| EP4050103A1 (en) * | 2014-04-07 | 2022-08-31 | Minerva Biotechnologies Corporation | Anti-nme antibody |
| EP3256494A4 (en) * | 2015-02-10 | 2018-12-05 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
| KR102611444B1 (ko) * | 2016-04-08 | 2023-12-06 | 지엘바이오, 인크. | 플렉틴-1 결합 항체 및 그의 용도 |
| WO2018187512A1 (en) * | 2017-04-04 | 2018-10-11 | Corvus Pharmaceuticals, Inc. | Methods for treating cd73hi tumors |
| WO2019075216A1 (en) * | 2017-10-11 | 2019-04-18 | Iti Health, Inc. D/B/A Zielbio | ANTIBODIES BINDING TO PELTIN-1 AND USES THEREOF |
| CN113164439A (zh) | 2018-12-06 | 2021-07-23 | 安索治疗公司 | 用于治疗或预防痛风或高尿酸血症的方法 |
| WO2020146902A2 (en) * | 2019-01-11 | 2020-07-16 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| EP3920693A4 (en) | 2019-02-04 | 2022-10-05 | Minerva Biotechnologies Corporation | ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS |
| JP2023530039A (ja) | 2020-06-08 | 2023-07-12 | ミネルバ バイオテクノロジーズ コーポレーション | 抗ｎｍｅ抗体および癌または癌転移の治療方法 |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| CA3248038A1 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0505566A1 (en) * | 1989-12-15 | 1992-09-30 | Takeda Chemical Industries, Ltd. | Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
| US5342947A (en) * | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
| WO2002078598A2 (en) * | 2001-03-29 | 2002-10-10 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Peptides and antibodies to muc 1 proteins |
| EP1425016B1 (en) * | 2001-09-05 | 2010-06-02 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
| EP1497649A4 (en) * | 2002-04-22 | 2006-03-22 | Dyax Corp | FOR MUCIN POLYPEPTIDE SPECIFIC ANTIBODIES |
| JP2006502110A (ja) * | 2002-07-03 | 2006-01-19 | イミュノジェン・インコーポレーテッド | 非放出Ｍｕｃ１およびＭｕｃ１６に対する抗体、およびその使用 |
| US8859495B2 (en) | 2005-03-30 | 2014-10-14 | Minerva Biotechnologies Corporation | Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors |
| US7825092B2 (en) * | 2006-08-08 | 2010-11-02 | University Of South Florida | Dendroaspis natriuretic peptide for treatment of cancer |
| US20090075926A1 (en) | 2006-12-06 | 2009-03-19 | Bamdad Cynthia C | Method for identifying and manipulating cells |
| US20100104626A1 (en) * | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| JP2012504961A (ja) * | 2008-10-06 | 2012-03-01 | ミネルバ バイオテクノロジーズ コーポレーション | Ｍｕｃ１＊抗体 |
| KR20160017117A (ko) * | 2008-10-09 | 2016-02-15 | 미네르바 바이오테크놀로지 코포레이션 | 세포내에서 다능성을 유도하기 위한 방법 |
| CA2741798A1 (en) * | 2008-10-28 | 2010-05-06 | Shionogi & Co., Ltd. | Anti-muc1 antibody |
| WO2010138171A2 (en) * | 2009-05-23 | 2010-12-02 | Incube Labs, Llc | Methods for cancer treatment using stem cells |
| MX2011013385A (es) * | 2009-06-11 | 2012-05-29 | Minerva Biotechnologies Corp | Metodos para cultivar celulas madre y celulas progenitoras. |
| EP3228629A1 (en) * | 2010-06-16 | 2017-10-11 | Minerva Biotechnologies Corporation | Reprogramming cancer cells |
-
2013
- 2013-08-14 AU AU2013302620A patent/AU2013302620B2/en active Active
- 2013-08-14 CN CN201810110588.4A patent/CN108175856B/zh active Active
- 2013-08-14 CN CN201380053708.7A patent/CN104717980A/zh active Pending
- 2013-08-14 JP JP2015527590A patent/JP6664219B2/ja active Active
- 2013-08-14 CN CN202010192670.3A patent/CN111388664A/zh active Pending
- 2013-08-14 EP EP13829213.1A patent/EP2885000A4/en active Pending
- 2013-08-14 WO PCT/US2013/055015 patent/WO2014028668A2/en not_active Ceased
- 2013-08-14 CA CA2882222A patent/CA2882222A1/en active Pending
-
2015
- 2015-02-13 US US14/622,677 patent/US9932407B2/en active Active
- 2015-02-15 IL IL237228A patent/IL237228B/en active IP Right Grant
-
2016
- 2016-12-28 US US15/392,858 patent/US20170121406A1/en not_active Abandoned
-
2017
- 2017-12-13 JP JP2017238427A patent/JP6757712B2/ja active Active
-
2018
- 2018-08-24 AU AU2018220126A patent/AU2018220126B2/en active Active
-
2020
- 2020-03-05 JP JP2020037396A patent/JP2020109101A/ja active Pending
-
2021
- 2021-11-08 JP JP2021181985A patent/JP2022025136A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201770T1 (hr) | Nova imunoterapija protiv raznih vrsta karcinoma, uključujući gastrointestinalni karcinom i gastrični karcinom | |
| Kawaguchi et al. | SYT‐SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the J apanese M usculoskeletal O ncology G roup | |
| CA2807942C (en) | Erythrocyte-binding therapeutics | |
| Takahashi et al. | First clinical trial of cancer vaccine therapy with artificially synthesized helper/killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen | |
| JP2016519933A5 (cg-RX-API-DMAC10.html) | ||
| JP2019516663A5 (cg-RX-API-DMAC10.html) | ||
| JP2019519215A5 (cg-RX-API-DMAC10.html) | ||
| EA202190587A2 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии гепатоклеточной карциномы (гкк) и других видов рака | |
| JP2010529026A5 (cg-RX-API-DMAC10.html) | ||
| JP2019513005A5 (cg-RX-API-DMAC10.html) | ||
| JP2020506690A5 (cg-RX-API-DMAC10.html) | ||
| JP2019536426A5 (cg-RX-API-DMAC10.html) | ||
| JP2017507936A5 (cg-RX-API-DMAC10.html) | ||
| JP2012102122A5 (cg-RX-API-DMAC10.html) | ||
| MY184576A (en) | Recombinant proteins and their therapeutic uses | |
| JP2015506961A5 (cg-RX-API-DMAC10.html) | ||
| CR20200495A (es) | NUEVOS PÉPTIDOS, COMBINACIONES DE PÉPTIDOS Y SOPORTES PARA EL USO EN EL TRATAMIENTO INMUNOTERAPÉUTICO DE VARIOS TIPOS DE CÁNCER (Divisional 2018-174) | |
| JP2019520038A5 (cg-RX-API-DMAC10.html) | ||
| RU2019113989A (ru) | Лекарственное средство | |
| RU2017134693A (ru) | Лекарственное средство | |
| NZ601980A (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| Lin et al. | Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma | |
| MX2022002293A (es) | Péptidos recombinantes inmunotolerantes similares a la elastina y métodos de uso. | |
| JP2019531254A5 (cg-RX-API-DMAC10.html) | ||
| JP2019520059A5 (cg-RX-API-DMAC10.html) |